Posted on April 26, 2022 by 0 DIAGNOS Announces the Extension of its Contract with Novo Nordisk for the Follow-up of Diabetic Patients Under Treatment with Drugs Included in its Therapeutic Portfolio – Yahoo Finance Share this: DIAGNOS Announces the Extension of its Contract with Novo Nordisk for the Follow-up of Diabetic Patients Under Treatment with Drugs Included in its Therapeutic Portfolio Yahoo Finance Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)